olaparib targets prostate cancer mutations Calcium-based binders, however, are associated with greater odds of all-cause mortality versus sevelamer. Phosphate-binder therapy does not reduce mortality ...
Please provide your email address to receive an email when new articles are posted on . Data released from the Dialysis Outcomes and Practice Patterns Study Program show use of the calcimimetic ...
Wilmington, Delaware, United States, May 17, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – The Global Lithium-ion Battery Binders Market is projected to flourish at a CAGR of 15.6% from ...
April 29, 2010 (Orlando, Florida) — Taking a proton pump inhibitor (PPI) with a phosphate binder might improve phosphorus control in patients on hemodialysis, according to a retrospective study ...
The medication may represent a new treatment option for dialysis patients, researchers concluded. A team led by Rong Wang, MD, of Shandong Provincial Hospital in Shandong, China, analyzed 8 randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback